Researchers evaluated the frequency of polyautoimmunity and its associated factors in a large retrospective cohort of patients with systemic lupus erythematosus.
Study data demonstrates an early benefit to receiving Japanese Encephalitis vaccination prior to CYD-TDV in terms of higher overall anti-dengue virus neutralizing titers, although this benefit appears to wane after several months.
Apheresis may be a useful adjunct treatment for patients with babesiosis, or loiasis.
Arakoda (tafenoquine; 60 Degrees Pharmaceuticals) has been made available in the US for the prevention of malaria in patients aged ≥18 years.
Diagnosing tick-borne encephalitis with commercial enzyme-linked immunosorbent assay may lack specificity and need confirmatory testing.
Researchers reviewed the recently released Lyme disease guidelines and addressed their appropriate inclusion of and association with psychiatric illnesses.
For patients with normal glucose-6-phosphate dehydrogenase activity in malaria-endemic areas where frequent relapsing strains of Plasmodium vivax are prevalent, a 7-day high-dose course of primaquine was noninferior to a 14-day course.
A Connecticut resident has died from eastern equine encephalitis (EEE), the first such death in the state since 2013.
Two new human cases of mosquito-borne Eastern equine encephalitis were confirmed by the Massachusetts Department of Public Health.
Dozens of communities at high or moderate risk for Eastern equine encephalitis
Eli Lilly was the only pharmaceutical company providing quinidine gluconate in the United States, but in November 2017 it stopped manufacturing the drug and the remaining supplies expired.
In patients with malaria who have normal levels of glucose-6-phosphate dehydrogenase, 7-day primaquine was well tolerated and noninferior to 14-day primaquine.
A total of 2,813 cases of domestic arboviral disease were identified in 2018, of which 94% were West Nile Virus.
Dihydroartemisinin plus piperaquine for treating multidrug-resistant Plasmodium falciparum malaria should no longer be used in southeast Asia as a result of new resistance mutations.
The FDA has cleared for marketing the ZEUS Borrelia Modified Two-Tiered Testing algorithm to help in the diagnosis of Lyme disease.
Lyme disease, a vector-borne illness caused by the bacteria Borrelia burgdorferi, is transmitted to humans by deer ticks. It is currently nearing endemic levels of infection in North America; the United States Centers for Disease Control and Prevention (CDC) has reported a 130.6% increase in confirmed cases between 1997 and 2017 (12,801-29,513 cases, respectively)1. Other…
Several sentinel chickens in the same flock have tested positive for Eastern Equine Encephalitis infection thus increasing risk of transmission to humans.
This is the first study to describe persistent joint pain and stiffness many months after infection with the chikungunya virus.
High-resolution maps of Plasmodium falciparum malaria informs where malaria elimination efforts should be strengthened by highlighting where burden remains high.
The CDC has summarized present and updated guidelines on dengue and Zika virus diagnostic testing in patients with a clinically compatible illness who live in or recently traveled to an endemic area.